Vernon J. Harvey
Auckland, AUK, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for ERBB2-Positive Breast Cancer: A Secondary Analysis of the SOLD Randomized Clinical Trial.
Journal: JAMA network open
Published: August 26, 2024
Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial.
Journal: Cancer
Published: August 19, 2020
Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial.
Journal: Breast cancer research and treatment
Published: August 11, 2020
Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy.
Journal: Breast cancer research and treatment
Published: February 04, 2020
Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 27, 2018
Bias in survival estimates created by a requirement for consent to enter a clinical breast cancer registry.
Journal: Cancer epidemiology
Published: October 11, 2018
PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial.
Journal: Breast cancer research : BCR
Published: September 19, 2018
The impact of different tumour subtypes on management and survival of New Zealand women with Stage I-III breast cancer.
Journal: The New Zealand medical journal
Published: May 18, 2018
Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index.
Journal: BMC cancer
Published: April 26, 2018
Long-term efficacy analysis of the randomised, phase II TRYPHAENA cardiac safety study: Evaluating pertuzumab and trastuzumab plus standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 01, 2017
Treatment and survival disparities by ethnicity in New Zealand women with stage I-III breast cancer tumour subtypes.
Journal: Cancer causes & control : CCC
Published: May 31, 2017
Last Updated: 09/26/2026